Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver FunctionRecruiting
NCT07231991Phase 1Updated Apr 3, 2026
Sponsor: Pfizer
Healthy Participants
United States
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060Completed
NCT07160738Phase 1Updated Apr 3, 2026
Sponsor: Pfizer
Healthy Adults
United States
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMACompleted
NCT04822350N/AUpdated Apr 2, 2026
Sponsor: Pfizer
Urothelial Carcinoma
France
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaReRecruiting
NCT06856902NAUpdated Apr 1, 2026
Sponsor: Technical University of Madrid
Cardiovascular Diseases · Endocrinology · Inmunology · Neurology
Germany, Italy, Netherlands, Norway, Portugal +3 more
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerRecruiting
NCT04486352Phase 1, Phase 2Updated Apr 1, 2026
Sponsor: Alliance Foundation Trials, LLC.
Endometrial Cancer
United States
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized StudyCompleted
NCT00522184Phase 3Updated Mar 31, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Rheumatoid Arthritis
France
Swedish Ibrance Registries Insights (SIRI)Recruiting
NCT04654208N/AUpdated Mar 31, 2026
Sponsor: Pfizer
Malignant Neoplasm of Breast
Sweden
A Study to Look at the Health Outcomes of Patients With COVID-19 and InfluenzaActive Not Recruiting
NCT05160636N/AUpdated Mar 31, 2026
Sponsor: Pfizer
COVID-19 · Coronavirus Disease 2019 · Influenza
United States
Crizotinib Continuation Clinical StudyActive Not Recruiting
NCT05160922Phase 4Updated Mar 30, 2026
Sponsor: Pfizer
NSCLC · ALCL · IMT
China, Italy, Japan, Russia, Taiwan
A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.Active Not Recruiting
NCT07161687N/AUpdated Mar 30, 2026
Sponsor: Pfizer
Hemophilia A or B
Japan
Safety and Efficacy of Xalkori ROS1Active Not Recruiting
NCT03375242N/AUpdated Mar 30, 2026
Sponsor: Pfizer
Non-small Cell Lung Cancer
Japan
Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid CardiomyopathyActive Not Recruiting
NCT04801329N/AUpdated Mar 30, 2026
Sponsor: Pfizer
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
South Korea
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)Recruiting
NCT03297606Phase 2Updated Mar 27, 2026
Sponsor: Canadian Cancer Trials Group
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
Canada
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy AdultsNot Yet Recruiting
NCT06507904Phase 1Updated Mar 27, 2026
Sponsor: Pfizer
Healthy
Post Marketing Surveillance(PMS) Study of Lorviqua in KoreaRecruiting
NCT05599412N/AUpdated Mar 27, 2026
Sponsor: Pfizer
Metastatic ALK+ Non Small Cell Lung Cancer
South Korea
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsCompleted
NCT04368728Phase 2, Phase 3Updated Mar 25, 2026
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
United States, Argentina, Brazil, Germany, South Africa +1 more
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerCompleted
NCT03915951Phase 2Updated Mar 24, 2026
Sponsor: Pfizer
Non-small Cell Lung Cancer
United States, Italy, Netherlands, South Korea, Spain
Checkpoint Inhibitor-induced Liver InjuryRecruiting
NCT04476563N/AUpdated Mar 24, 2026
Sponsor: University of Nottingham
Immune-Mediated Hepatitis
United Kingdom
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy IntegrationRecruiting
NCT06762379N/AUpdated Mar 24, 2026
Sponsor: European Institute of Oncology
Metastatic Prostate Cancer (mPC)
Italy
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast CancerCompleted
NCT04539938Phase 2Updated Mar 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2 Positive Breast Cancer
United States
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerTerminated
NCT06580938Phase 1Updated Mar 23, 2026
Sponsor: Pfizer
Non Small Cell Lung Cancer · Bladder Cancer · Renal Cell Carcinoma · Melanoma
United States
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic ArthritisCompleted
NCT01500551Phase 2, Phase 3Updated Mar 23, 2026
Sponsor: Pfizer
Juvenile Idiopathic Arthritis
United States, Argentina, Australia, Belgium, Brazil +14 more
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy AdultsRecruiting
NCT06994897Phase 1Updated Mar 20, 2026
Sponsor: Pfizer
Healthy
Belgium
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of InfluenzaCompleted
NCT05227001Phase 1Updated Mar 20, 2026
Sponsor: Pfizer
Influenza, Human
United States
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerRecruiting
NCT05748834Phase 2Updated Mar 20, 2026
Sponsor: SCRI Development Innovations, LLC
Breast Cancer
United States

Previous page Next page